4//SEC Filing
Dickinson Andrew D 4
Accession 0001310204-25-000021
CIK 0000882095other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 6:31 PM ET
Size
4.8 KB
Accession
0001310204-25-000021
Insider Transaction Report
Form 4
Dickinson Andrew D
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-12-15$122.00/sh−3,000$366,000→ 153,503 total
Footnotes (1)
- [F1]The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.
Documents
Issuer
GILEAD SCIENCES, INC.
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001310204
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 6:31 PM ET
- Size
- 4.8 KB